ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
ma420
|
127 |
34K |
1 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
127
|
34K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
ma420
|
127 |
34K |
2 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
127
|
34K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
ma420
|
127 |
34K |
2 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
127
|
34K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
ma420
|
127 |
34K |
5 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
127
|
34K
|
5
|
|
ASX - By Stock
|
DXB |
Re:
Dimerix (ASX: DXB) Discussion Thread
|
|
ma420
|
640 |
219K |
3 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
640
|
219K
|
3
|
|
ASX - By Stock
|
DXB |
Re:
Dimerix (ASX: DXB) Discussion Thread
|
|
ma420
|
640 |
219K |
1 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
640
|
219K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Dimerix (ASX: DXB) Discussion Thread
|
|
ma420
|
640 |
219K |
1 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
640
|
219K
|
1
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Successful Completion of Retail Entitlement Offer
|
|
ma420
|
5 |
2.2K |
9 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
5
|
2.2K
|
9
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
ma420
|
684 |
226K |
6 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
684
|
226K
|
6
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
ma420
|
684 |
226K |
10 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
684
|
226K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
ma420
|
261 |
74K |
1 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
261
|
74K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
ma420
|
261 |
74K |
2 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
261
|
74K
|
2
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
ma420
|
684 |
226K |
10 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
684
|
226K
|
10
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
ma420
|
11K |
3.8M |
5 |
23/04/24 |
23/04/24 |
General
|
11K
|
3.8M
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
ma420
|
261 |
74K |
8 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
261
|
74K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
ma420
|
261 |
74K |
5 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
261
|
74K
|
5
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
ma420
|
11K |
3.8M |
22 |
23/04/24 |
23/04/24 |
General
|
11K
|
3.8M
|
22
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
ma420
|
11K |
3.8M |
12 |
23/04/24 |
23/04/24 |
General
|
11K
|
3.8M
|
12
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
ma420
|
21K |
7.4M |
7 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
21K
|
7.4M
|
7
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
ma420
|
2.2K |
754K |
7 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
2.2K
|
754K
|
7
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
ma420
|
11K |
3.8M |
7 |
19/04/24 |
19/04/24 |
General
|
11K
|
3.8M
|
7
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Clarity launches $121 million equity raise
|
|
ma420
|
90 |
37K |
6 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
90
|
37K
|
6
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
ma420
|
684 |
226K |
4 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
684
|
226K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
ma420
|
127 |
34K |
13 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
127
|
34K
|
13
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
ma420
|
127 |
34K |
14 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
127
|
34K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust makes Head of Manufacturing appointment
|
|
ma420
|
37 |
9.7K |
5 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
37
|
9.7K
|
5
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Clarity launches $121 million equity raise
|
|
ma420
|
90 |
37K |
7 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
90
|
37K
|
7
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Trading Halt
|
|
ma420
|
86 |
20K |
0 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
86
|
20K
|
0
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust makes Head of Manufacturing appointment
|
|
ma420
|
37 |
9.7K |
22 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
37
|
9.7K
|
22
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust makes Head of Manufacturing appointment
|
|
ma420
|
37 |
9.7K |
28 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
37
|
9.7K
|
28
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Trading Halt
|
|
ma420
|
86 |
20K |
2 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
86
|
20K
|
2
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Trading Halt
|
|
ma420
|
86 |
20K |
3 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
86
|
20K
|
3
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Trading Halt
|
|
ma420
|
86 |
20K |
1 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
86
|
20K
|
1
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Trading Halt
|
|
ma420
|
86 |
20K |
2 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
86
|
20K
|
2
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Trading Halt
|
|
ma420
|
86 |
20K |
3 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
86
|
20K
|
3
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Investor Webinar on Clinical Trial Results
|
|
ma420
|
3 |
1.2K |
2 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
3
|
1.2K
|
2
|
|
ASX - By Stock
|
AS2 |
Re:
Ann: Askari Defines Maiden Mineral Resource at Burracoppin Gold
|
|
ma420
|
19 |
4.9K |
7 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
19
|
4.9K
|
7
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
ma420
|
21K |
7.4M |
11 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
21K
|
7.4M
|
11
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
ma420
|
21K |
7.4M |
5 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
21K
|
7.4M
|
5
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
ma420
|
21K |
7.4M |
12 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
21K
|
7.4M
|
12
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
267 |
111K |
8 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
267
|
111K
|
8
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
267 |
111K |
6 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
267
|
111K
|
6
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
ma420
|
537 |
184K |
15 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
537
|
184K
|
15
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
ma420
|
1.0K |
299K |
2 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
1.0K
|
299K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
ma420
|
1.0K |
299K |
1 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
1.0K
|
299K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final Ethics Approval for Open-Label MND Extension Study
|
|
ma420
|
77 |
20K |
8 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
77
|
20K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final Ethics Approval for Open-Label MND Extension Study
|
|
ma420
|
77 |
20K |
10 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
77
|
20K
|
10
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
267 |
111K |
11 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
267
|
111K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final Ethics Approval for Open-Label MND Extension Study
|
|
ma420
|
77 |
20K |
2 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
77
|
20K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final Ethics Approval for Open-Label MND Extension Study
|
|
ma420
|
77 |
20K |
1 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
77
|
20K
|
1
|
|